reports
- Jonathan Moreland
TPC TUTOR PERINI CORPORATION
TCBI TEXAS CAPITAL BANCSHARES INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
HTGC HERCULES CAPITAL INC.
GPK GRAPHIC PACKAGING HOLDING COMPANY
NWPP NEW PEOPLES BANKSHARES INC.
SSP THE E.W. SCRIPPS COMPANY
KKR KKR & CO. INC.
EOSE EOS ENERGY ENTERPRISES INC (A)
SLRC SOLAR CAPITAL LTD.
PFX PHENIXFIN CORP
NPWR NET POWER INC
NCDL NUVEEN CHURCHILL DIRECT LENDING CORP
MSDL MORGAN STANLEY DIRECT LENDING
EDSA EDESA BIOTECH INC
HYMC HYCROFT MINING HOLDING CORPORATION
New Mountain Finance Corp: 1 director
A director at New Mountain Finance Corp bought 437,400 shares at 8.039USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Vera Therapeutics Appoints Christopher Hite to Board of Directors
Vera Therapeutics Appoints Christopher Hite to Board of Directors BRISBANE, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Christopher Hite, an accomplished executive with decades of corporate and financial strategy leadership experience in the biopharmaceutical sector, to Vera Therapeutics’ Board of Directors. "It is a pleasure to welcome Chris to our Board of Directors at this...
- Jonathan Moreland
RUN SUNRUN INC.
PYPL PAYPAL HOLDINGS INC
NMFC NEW MOUNTAIN FINANCE CORPORATION
GPK GRAPHIC PACKAGING HOLDING COMPANY
FMNB FARMERS NATIONAL BANC CORP.
DIN DINE BRANDS GLOBAL INC.
ACIW ACI WORLDWIDE INC.
WD WALKER & DUNLOP INC.
TTEC TELETECH HOLDINGS
AXR INC.
PCB AMREP
TSLX PACIFIC CITY FINANCIAL CORP
FOUR SIXTH STREET SPECIALTY LENDING
THRY INC.
EOSE SHIFT4 PAYMENTS
LUNG INC.
AIRS THRYV HOLDINGS
TTD EOS ENERGY ENTERPRISES INC (A)
FBRT PULMONX
BLCO AIRSCULPT TECHNOLOGIES INC
GTE THE TRADE DESK
EDSA FRANKLIN BSP REALTY TRUST INC
LAW BAUSCH + LOMB CORP
PMN GRAN TIERRA ENERGY INC.
EDESA BIOTECH INC
CS DISCO INC
PROMIS NEUROSCIENCES INC.
- Jonathan Moreland
ZBRA ZEBRA TECHNOLOGIES CORPORATION CLASS A
XRAY DENTSPLY SIRONA INC.
VNO VORNADO REALTY TRUST
TCBI TEXAS CAPITAL BANCSHARES INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
MTDR MATADOR RESOURCES COMPANY
FFIN FIRST FINANCIAL BANKSHARES INC
WD WALKER & DUNLOP INC.
AUP AURINIA PHARMACEUTICALS INC.
SABR SABRE CORP.
TREX TREX COMPANY INC.
AJG ARTHUR J. GALLAGHER & CO.
KKR KKR & CO. INC.
SMCI SUPER MICRO COMPUTER
AHCO INC.
DCTH ADAPTHEALTH
TSLX DELCATH SYSTEMS
THRY SIXTH STREET SPECIALTY LENDING
EOSE INC.
AGL THRYV HOLDINGS
FRSH EOS ENERGY ENTERPRISES INC (A)
FA AGILON HEALTH
CMTG INC.
MYN FRESHWORKS INC.
WRB FIRST ADVANTAGE CORP NEW
BLCO CLAROS MORTGAGE TRUST
NMTC INC.
MSDL BLACKROCK MUNIYELD N Y INSD FD INC
LAW W.R. BERKLEY CORPORATION
BAUSCH + LOMB CORP
NEUROONE MEDICAL TECHNOLOGIES CORP
MORGAN STANLEY DIRECT LENDING
CS DISCO INC
Moody's Ratings assigns B1 rating to Matador's proposed senior unsecur...
Moody's Ratings (Moody's) assigned a B1 rating to Matador Resources Company's ("Matador") proposed $750 million senior unsecured notes due 2034. Matador's other ratings, including its Ba3 corporate family rating ("CFR") and stable outlook, remain unchanged. The net proceeds from this debt issuance...
- Laura Chico
- Thomas Yip
Vera Therapeutics Provides Business Update and Reports Full Year 2025 ...
Vera Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results Positive Phase 3 data from ORIGIN 3 study of atacicept in IgA nephropathy (IgAN) presented at American Society of Nephrology (ASN) Kidney Week and published in the New England Journal of MedicineU.S. Food and Drug Administration (FDA) granted priority review to Biologics License Application (BLA) for atacicept with Prescription Drug User Fee Act (PDUFA) date of July 7, 2026; potential commercial launch of atacicept expected in mid-2026Strong balance sheet bolstered by equity and debt financings in 2025 e...
AMG Appoints G. Staley Cates to its Board of Directors
AMG Appoints G. Staley Cates to its Board of Directors Karen L. Alvingham to Retire from Board of Directors WEST PALM BEACH, Fla., Feb. 26, 2026 (GLOBE NEWSWIRE) -- AMG, a strategic partner to leading independent investment management firms globally, today announced the appointment of G. Staley Cates to its Board of Directors (the “Board”), effective April 1, 2026; the Company also announced the forthcoming retirement of Karen L. Alvingham from the Board, effective April 1, 2026. Lady Alvingham was appointed to AMG’s Board of Directors in January 2018. Mr. Cates served as the Vice Chai...
Enovix Reports Fourth Quarter and Full Year 2025 Results
Enovix Reports Fourth Quarter and Full Year 2025 Results Lead Smartphone Customer Qualification Progressing FREMONT, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: ENVX) (“Enovix”), a developer and manufacturer of advanced lithium-ion batteries, including proprietary silicon-anode architectures, today reported financial results for the fourth quarter and full year ending 2025. The Company will host a live webcast today, Wednesday February 25th, at 5:00 PM ET / 2:00 PM PT to discuss the results and provide a business update. To register for the webcast, please visit: . Qualificati...
Vera Therapeutics to Participate at Upcoming Investor Conferences
Vera Therapeutics to Participate at Upcoming Investor Conferences BRISBANE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company’s management team will present and participate in one-on-one meetings at upcoming investor conferences. Investor Conference Details: TD Cowen 46th Annual Health Care ConferenceFormat: Fireside chat and 1x1 investor meetings Webcast: Date: ...
- Jonathan Moreland
VRNS VARONIS SYSTEMS INC.
UEPS NET 1 U.E.P.S. TECHNOLOGIES INC.
TWI TITAN INTERNATIONAL INC.
SLP SIMULATIONS PLUS
SCSC SCANSOURCE INC.
PSEC PROSPECT CAPITAL CORPORATION
PAYX PAYCHEX INC.
NG. NOVAGOLD RESOURCES INC.
MOH MOLINA HEALTHCARE INC.
MMS MAXIMUS INC.
LMAT LEMAITRE VASCULAR INC.
KVHI KVH INDUSTRIES INC.
GKOS GLAUKOS CORP
CINF CINCINNATI FINANCIAL CORPORATION
BMI BADGER METER INC.
ARE ALEXANDRIA REAL ESTATE EQUITIES INC.
ARCC ARES CAPITAL CORPORATION
ASA ASA
PRU PRUDENTIAL PLC
TSI TCW STRATEGIC INCOME FUND INC.
PLBC PLUMAS BANCORP
GRF EAGLE CAPITAL GROWTH FUND INC
LW LAMB WESTON HOLDINGS INC.
HWKN HAWKINS INC.
WDFC WD-40 COMPANY
PW POWER REIT
ABT ABBOTT LABORATORIES
KKR KKR & CO. INC.
AXR AMREP
SONO SONOS
TENB TENABLE HOLDINGS
AVTR AVANTOR
CMTV INC.
AON COMMUNITY BANCORP INC. VT
BSTZ AON PLC CLASS A
AFRM BLACKROCK SCIENCE AND TECHNOLOGY TRUST II
INTA AFFIRM HOLDINGS
TMC INTAPP INC
CHRW TMC THE METALS CO INC
TBBK C.H. ROBINSON WORLDWIDE
FRST INC.
QDEL THE BANCORP
CHUC INC.
PMN PRIMIS FINANCIAL CORP
HYMC QUIDEL CORP
CING CHARLIES HLDGS INC
SPGI PROMIS NEUROSCIENCES INC.
HYCROFT MINING HOLDING CORPORATION
CINGULATE INC
MCGRAW HILL FINANCIAL INC
AMG Reports Financial and Operating Results for the Fourth Quarter and...
AMG Reports Financial and Operating Results for the Fourth Quarter and Full Year 2025 Company reports Diluted EPS of $11.21, Economic EPS of $9.48 in the fourth quarter of 2025Diluted EPS of $22.74, Economic EPS of $26.05 for the full year 2025 Net client cash inflows of approximately $29 billion in 2025, including approximately $12 billion in the fourth quarter, driven by ongoing momentum in alternative strategiesFull-year Net income (controlling interest) of $717 million, Economic net income (controlling interest) of $769 millionFull-year Economic EPS of $26.05 increased 22% year-over-ye...
AMG Expands Its Partnership with Garda Capital Partners with Increased...
AMG Expands Its Partnership with Garda Capital Partners with Increased Investment Increased investment deepens AMG’s partnership with Garda, a leading liquid alternatives manager specializing in fixed income relative value, with an excellent long-term investment track recordGarda will remain majority-owned and led by its management teamTransaction is aligned with AMG’s long-term growth strategy and further expands Company’s exposure to alternative strategies through an increased investment in an attractive, differentiated liquid alternatives manager WEST PALM BEACH, Fla., Feb. 12, 2026 (...
AMG Announces Partnership with HighBrook Investors
AMG Announces Partnership with HighBrook Investors AMG invests in HighBrook, a real estate investment manager specializing in thematic value-add opportunities in the U.S. and EuropeHighBrook to leverage AMG’s strategic capabilities to enhance its long-term success and continue to build an enduring firmPartnership further diversifies AMG’s business and expands its participation in global private markets WEST PALM BEACH, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- AMG, a strategic partner to leading independent investment management firms globally, today announced its acquisition of a minorit...
Enovix to Release Fourth Quarter and Full Year 2025 Financial Results ...
Enovix to Release Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 FREMONT, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX) (“Company” or “Enovix”), a global high-performance battery company, today announced it will release financial results for the fourth quarter and full year 2025 on Wednesday, February 25, 2026, after the close of the market. Enovix will hold a live video call at 2:00 PM PT / 5:00 PM ET on February 25, 2026, to discuss the company’s business updates, key milestones, and financial results. To join the call, participan...
- Jonathan Moreland
Insider Sales Into Price Weakness InsiderInsights.com Daily Ratings Re...
InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
UEPS NET 1 U.E.P.S. TECHNOLOGIES INC.
NG. NOVAGOLD RESOURCES INC.
GKOS GLAUKOS CORP
BMI BADGER METER INC.
ARCC ARES CAPITAL CORPORATION
PW POWER REIT
INTA INTAPP INC
TMC TMC THE METALS CO INC
TBBK THE BANCORP
KVUE INC.
SI KENVUE INC
CING SHOULDER INNOVATIONS INC
CINGULATE INC
- Jonathan Moreland
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rul...
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on February 2, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 11,500 shares of Class A common stock and restricted stock units (RSUs) underlying 5,750 shares of Class A common stock to two (2) new employees under the Vera Therapeutics, Inc. 2024 Inducement Plan...
AMG to Announce Fourth-Quarter and Full-Year Results on February 12, 2...
AMG to Announce Fourth-Quarter and Full-Year Results on February 12, 2026 Conference Call Scheduled for 8:30 a.m. Eastern Time WEST PALM BEACH, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- AMG (NYSE: AMG) will report financial and operating results for the fourth quarter and full year ended December 31, 2025 on Thursday, February 12, 2026. A conference call will be held at 8:30 a.m. Eastern time on the same day. In addition to quarterly results, the conference call may include discussion of management’s expectations of future financial and operating results. Jay C. Horgen, Chief Execut...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.